Lilly Acquires Calytrix Bio To Advance Treatments For Essential Thrombocythemia And Myelofibrosis RTT News 5d
Lilly agrees to acquire Calytrix Bio for $1.5bn Hospital Management 4d Calytrix Bio Pharma All sources
Retatrutide brought up to half of nondiabetic sleep apnea patients to mild or no disease in nejm trials Medical Daily 3d Foundayo Pharma All sources
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China AsiaOne 09:17 Fri, 13 Nov Novo Nordisk Pharma GLP-1 All sources